SCHEMBL11852695

SCHEMBL11852695

CC(=O)[C@@]1(O)[C@@H](C)C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@H]3[C@@H](O)C[C@@]21C

nearest known ligand 0.81

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ NR3C1 P04150 16/20 0.81
▸ PGR P06401 4/20 0.70
▸ HIF1A Q16665 3/20 0.70
▸ LMNA P02545 1/20 0.70
▸ NR1I2 O75469 1/20 0.70
▸ CNR1 P21554 1/20 0.70
▸ HSD17B10 Q99714 2/20 0.60
▸ CYP3A4 P08684 1/20 0.60
▸ ABCB11 O95342 1/20 0.60
▸ TNF P01375 1/20 0.60
▸ IL6 P05231 1/20 0.60
▸ SERPINA6 P08185 1/20 0.60
▸ NR3C2 P08235 1/20 0.60
▸ AR P10275 1/20 0.60
▸ GLUL P15104 1/20 0.60
▸ ADAM17 P78536 1/20 0.60
▸ GPBAR1 Q8TDU6 1/20 0.60
▸ CYP2C19 P33261 1/20 0.60

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10497255 1.00 NR3C1 (0.81) NR3C1PGRHIF1ALMNANR1I2
SCHEMBL10589155 1.00 NR3C1 (0.81) NR3C1PGRHIF1ALMNANR1I2
SCHEMBL10497270 1.00 NR3C1 (0.81) NR3C1PGRHIF1ALMNANR1I2
SCHEMBL11415092 1.00 NR3C1 (0.81) NR3C1PGRHIF1ALMNANR1I2
SCHEMBL11573398 0.92 NR3C1 (0.81) NR3C1PGRHIF1ALMNANR1I2
SCHEMBL12396736 0.92 NR3C1 (0.81) NR3C1PGRHIF1ALMNANR1I2
SCHEMBL14260030 0.91 NR3C1 (0.70) NR3C1PGRHIF1ALMNANR1I2
SCHEMBL2108379 0.91 NR3C1 (0.70) NR3C1PGRHIF1ALMNANR1I2
SCHEMBL2108405 0.91 NR3C1 (0.70) NR3C1PGRHIF1ALMNANR1I2
SCHEMBL11808825 0.90 NR3C1 (0.78) NR3C1PGRHIF1ALMNANR1I2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-3984544-A Retinoic acid esters of steroids of the pregnane series, their use in the treatment of acne and pharmaceutical formulations useful therefor SCHERING CORPORATION (US) 1976-10-05 — — US disclosed
Send feedback